Eisai's success against Alzheimer's has been long time coming; tobacco companies turn to gas station ads to fight FDA menthol ban

It took 25 years after the company's introduction of Aricept to develop another Alzheimer's treatment that proved effective in human trials. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      STAT+: 'We were right all along:' For Japanese drugmaker Eisai, success against Alzheimer's has been a long time coming By Adam Feuerstein and Jason Mast and Damian Garde Chantal Heijnen for STAT It took 25 years after the company's introduction of Aricept to develop another Alzheimer's treatment that proved effective in human trials. Read More To gin up opposition to the proposed menthol ban, tobacco companies are turning to gas station ads By Nicholas Florko Michael M. Santiago/Getty Images At the Gateway mini mart here, you can submit a formal comment to regulators at the Food and Drug Administration. Read More STAT+: Editas, facing another setback, halts development on first clinical CRISPR program By Jason Mast Ruby Wallau for STAT The news marks another setback for a biotech that has long lagged behind its rivals and, in recent years, faced significant turnover. Read More Sponsored Insight by YouTube How YouTube Health’s new feature helps licensed healthcare professionals reach people on YouTube Last week, the platform announced that for the first time, certain categories of eligible healthcare professionals can apply to be included in YouTube's health features, which help viewers determine credible health content by marking sources as authoritative and highlighting their videos in relevant search results. This new step, guided by principles from the Council of Medical Specialty Societies, the National Academy of Medicine and the World Health Organization, will further the platform's mission of helping people more easily navigate and evaluate health information online. Learn more. In country after country, primary care doctors report high burnout and degraded patient care By Andrew Joseph DANIEL LEAL/AFP via Getty Images A survey revealed similar levels of doctor burnout even in countries with vastly different experiences during the pandemic. Read More In armadillos, leprosy expands healthy liver tissue. Could that tell us something about regenerating our own? By Eric Boodman Adobe The researchers hope the finding might unlock some bacterial regenerative secret, but they're a long way from showing it works in humans. Read More STAT+: Vertex revolutionized cystic fibrosis treatment. Its executives say that's just the start By Jonathan Wosen STAT “Our goal for ourselves was to do what we have already done with cystic fibrosis again, and again, and again,” said CEO Reshma Kewalramani. Read More Opinion: We know what it's like to live in fear of polio. We also know how to stop it By Rose Gana Fomban Leke and Zulfiqar Bhutta Farooq Naeem / Getty Polio, like every virus, knows no borders. All countries need to pitch in and apply lessons learned in countries dealing with it. Read More Listen: Roche's failure, Eisai's success, and a live AMA By Damian Garde and Allison DeAngelis and Adam Feuerstein Recorded live from the 2022 STAT Summit, we discuss the failure of one Alzheimer's disease treatment and the unexpected success of another. Read More Thursday, November 17, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser